European Hemostats & Sealants Market

The European hemostats and sealants (focused brands) market is projected to reach USD 89 million by 2024 from USD 63 million in 2019, at a CAGR of 7.0%. Growth in this market is mainly driven by the favorable reimbursement scenario for the usage of hemostats in various surgeries. However, the shift towards minimally invasive surgeries over open surgeries is a major restraint for this market.

Hemostats help in controlling bleeding at the site of wound or performing various open surgeries. The different types of products used include thrombin-based hemostats, combination hemostats, oxidized regenerated cellulose-based hemostats, gelatin-based hemostats, and collagen-based hemostats. Of these, combination hemostats are anticipated to grow at the highest rate in Europe, as they reduce the risk of side-effects post-application

To know about the assumptions considered for the study download the pdf brochure

The market for hemostats and sealants is anticipated to grow mainly due to the launch of the new products, M&A’s, and favorable reimbursement scenario in Europe. However, the increasing preference for minimally invasive surgeries and the reducing preference for the usage of hemostats while performing surgeries are expected to hinder the growth of this market during the forecast year. Leading players operating in this market are Ethicon (J&J), Baxter, Pfizer, Baxter, C. R. Bard, and B. Braun.

Focused brands for this study are Hemopatch (Baxter), Tachosil (Takeda), Veriset (Medtronic), Avitene (C. R. Bard), and Sangustop & Lyostypt (B Braun).

Related Reports:

European Hemostats & Sealants Market by Brand (Hemopatch [Baxter], Tachosil [Takeda], Veriset [Medtronic], Avitene [C.R Bard], Sangustop [B Braun], Lyostypt [B Braun]), Country (Germany, Uk, France, Italy & Spain) - Forecast to 2024

Contact:
Mr. Shelly Singh
MarketsandMarkets™ INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA : 1-888-600-6441
[email protected]